Mazdutide
Mazdutide
A synthetic oxyntomodulin analog and dual GLP-1/glucagon receptor agonist developed by Innovent Biologics (licensed to Eli Lilly in Western markets). Approved in China (2025) for weight management; not approved by the FDA or EMA.
$ 250
FOR LABORATORY / RESEARCH USE ONLY. Not for human use or consumption. Not for animal or veterinary use or testing. Not a drug, food, cosmetic, or medical device, and not evaluated or approved by the FDA.
